A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine - Concepedia

Concepedia

Publication | Open Access

A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine

DOI Full Paper Access

38

Citations

33

References

2015

Year

Chantal Mathieu, R. Ravi Shankar, Daniel Lorber, Guillermo E. Umpierrez, Fan Wu, Lei Xu, Gregory T. Golm, Melanie Latham, Keith D. Kaufman, Samuel S. Engel

Diabetes Therapy

Abstract

Merck & Co., Inc., Kenilworth, NJ, USA.

References

	Year	Citations
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) S. E. Inzucchi, Richard M. Bergenstal, John B. Buse, Diabetologia Metabolic SyndromeDiabetes ManagementHealth PolicyDiabetesType 2	2012	3.9K
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus Christian Weyer, Clifton Bogardus, David M. Mott, Journal of Clinical Investigation	1999	1.9K
The Treat-to-Target Trial Matthew C. Riddle, Julio Rosenstock, John Gerich Diabetes Care	2003	1.5K
Comparative analysis of two rates Olli S. Miettinen, Markku Nurminen Statistics in Medicine EngineeringComparative TestStatistical FoundationRate RatioMathematical Statistic	1985	1.1K
Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes Pablo Aschner, Mark Kipnes, Jared Lunceford, Diabetes Care	2006	878
Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379 SE Inzucchi, RM Bergenstal, M. Diamant, Diabetes Care Metabolic SyndromeDiabetes ManagementDiabetes EpidemiologyInsulin ManagementDiabetes	2013	807
Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone B Charbonnel, Avraham Karasik, Ji Liu, Diabetes Care	2006	786
Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin Kjeld Hermansen, Mark Kipnes, Edmund Luo, Diabetes Obesity and Metabolism	2007	522
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study Julio Rosenstock, Ronald Brazg, Paula J. Andryuk, Clinical Therapeutics Diabetes ManagementMedicinePioglitazone TherapyDiabetesInsulin Management	2006	513
Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study H Yki-Järvinen, Mirja Tiikkainen, Markku Vähätalo, Diabetologia Metabolic SyndromeDiabetes ManagementInsulin GlargineInsulin ManagementDiabetes	2006	435

Page 1